Biocon’s ESG Score Rises to 69 in 2024, Biocon Biologics Debuts with 53

Bengaluru, January 27, 2025 – Biocon Limited has recorded a six-point improvement in its S&P Global ESG Score, reaching 69 in 2024 compared to 63 in 2023. The company now ranks in the 98th percentile among global biotechnology peers, demonstrating significant progress in its Environmental, Social, and Governance (ESG) initiatives.
Meanwhile, Biocon Biologics, a subsidiary of Biocon, participated for the first time in the S&P Global Corporate Sustainability Assessment (CSA) and achieved an ESG score of 53.

Breakdown of Biocon's ESG Performance​

• Environmental Dimension: 76, up from 69 in 2023, reflecting improvements in sustainability, energy efficiency, and water management.
• Social Dimension: 74, up from 62, highlighting progress in human capital management and workplace policies.
• Governance & Economic Dimension: 62, showcasing a continued commitment to corporate governance, ethics, and transparency.

Biocon's 90% disclosure rate and 97% additional reporting availability to S&P Global further highlight its commitment to transparency.

Leadership Commentary​

Siddharth Mittal, CEO & MD, Biocon Limited:
"The six-point increase in ESG score reflects our commitment to embedding sustainable practices across operations. We remain focused on reducing greenhouse gas emissions, improving water conservation, and advancing circular economy waste management."
Shreehas Tambe, CEO & MD, Biocon Biologics:
"This is the first time Biocon Biologics participated independently, and we are proud to debut with an ESG score of 53. We aim to minimize environmental impact while ensuring wider access to lifesaving medicines."

Strategic Implications​

The improved ESG scores enhance Biocon's credibility with global investors, positioning it as a sustainable biotechnology and pharmaceuticals leader. The company continues to focus on climate-conscious manufacturing, ethical corporate governance, and social responsibility, aligning with global sustainability goals.